Piezo1: the key regulators in central nervous system diseases.

The inhibition rate of Tubeimoside1 showed a decreasing trend with increasing Yoda1 concentration, which suggests that it competes with Yoda1 for the binding site to achieve inhibition ( Liu S. et al., 2020 ). 5.3.

also in 47,180 other papers